Searched for
OTSUKA PHARMACEUTICAL CO S
Alembic Pharma gets USFDA nod to market generic antidepressant drugThe company's product is therapeutically equivalent to Otsuka Pharmaceutical Co's reference listed drug product Rexulti tablets, it added. ...- Lupin gets tentative nod from USFDA to market generic Brexpiprazole tabletsThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Brexpiprazole tab...
- Mylan, TB Alliance seeks clinical trial waiver for Pretomanid drugPretomanid, a new oral treatment is a shorter more convenient option for people with extensively drug resistant (XDR) TB. The dossier for g...
- Nikkei retreats from 4.5-month high; Canon slumps on profit warningThe Nikkei share average dropped 0.84 per cent to 22,090.12, after touching the highest level since early December on the previous day.
- Japanese companies make cautious return to Indian pharma marketOther drug companies whose acquisition went southwards included Mitsui & Co, which acquired a significant stake in Arch Pharma.
- Limited options in food and lifestyle for Japanese investors and employess in GujaratAhmedabad has just one restaurant serving Japanese food, Café Formula by Tamura, a joint initiative between Japanese restaurant chain Tamur...
- Claris Lifesciences completes transfer of Speciality Injectable BusinessShareholders of the company approved the transfer along with all employees, assets and liabilities at a consideration not less than its boo...
- Fifteen stocks in focus in Thursday morning tradeIndian markets are expected to trade in a range. Here is a list of fifteen stocks which are likely to be in focus today.
- Claris to buy-back 14.49 per cent stake for Rs 231.25 crore"The objective of the buy-back is to return surplus cash to the equity shareholders of the company," Claris said in a filing to the BSE.
- Claris transfers two businesses to Japan JV for Rs 1,050 crClaris will continue to hold a 20 per cent stake in the JV, while Otsuka and Mitsui will hold 60 and 20 per cent in it, respectively, a com...
- Claris Lifesciences gets FIPB nod for Japanese JV, Q1 net down by 29%Ahmedabad-based Claris Lifesciences registered de-growth of 29% in its first quarter ended on 31st March 2013.
- Claris Lifesciences to invest Rs 900 crore on business growth, pre-payment of debtClaris Lifesciences on Thursday said it will invest Rs 900 crore, which it expects to receive as part of divestment of 80 per cent stake in...
- Claris Lifesciences inks JV with Japanese drug maker Otsuka Pharma & Mitsui for Indian marketAhmedabad-based Claris Lifesciences Limited, India executed agreements for a Joint Venture with two Japan-based drug makers Otsuka Pharmace...
- Otsuka commences unit's production in RajasthanOtsuka Chemical India (OCIL), a wholly-owned subsidiary of Japanese company Ostuka Chemical Co. Ltd, on Friday announced commencement of pr...
- Bristol-Myers to shut half of its plants in 3 yearsApart from plant shutdowns, the company plans to lay off about 4,300 employees in a broad restructuring aimed at cost savings of $1.5 b by ...
Load More
